Early treatment with cyclosporin a ameliorates the reduction of muscarinic acetylcholine receptors in gerbil hippocampus after transient forebrain ischemia

Yoichi Kondo, Masato Asanuma, Emi Iwata, Fumio Kondo, Ikuko Miyazaki, Norio Ogawa

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Recent evidence has suggested that cyclosporin A (CsA), an immunosuppressive agent, has neuroprotective properties. However, its mechanisms associated with this activity remain unclear. We have previously shown that post-ischemic administration of CsA daily for 14 days prevented the decrease of muscarinic acetylcholine receptor binding in the hippocampus in the gerbil model of 5-min transient forebrain ischemia. In the present study, CsA (5 mg/kg, subcutaneously) was administered to each animal just after, 2 and 6 h after ischemia so as not to exert its immunosuppressive effect. Initial CsA treatment significantly restored the declined muscarinic acetylcholine receptor binding of the hippocampus 14 days after ischemia similar to the previous report. However, CsA did not alter reactive changes of astrocytes and microgila in the CA1 area of the hippocampus, which had been suppressed by daily administration. These results indicate that CsA could positively modulate the hippocampal acetylcholine neurotransmission system broken down through the ischemia-induced pyramidal cell death and its action mechanism may have no relation to the immunosuppressive properties.

Original languageEnglish
Pages (from-to)9-13
Number of pages5
JournalNeurochemical Research
Volume24
Issue number1
DOIs
Publication statusPublished - 1999

Fingerprint

Gerbillinae
Muscarinic Receptors
Prosencephalon
Cyclosporine
Hippocampus
Ischemia
Immunosuppressive Agents
Pyramidal Cells
Cell death
Synaptic Transmission
Astrocytes
Acetylcholine
Animals
Cell Death

Keywords

  • Acetylcholine receptor
  • Cyclosporin A
  • Gerbil
  • Hippocampus
  • Ischemia

ASJC Scopus subject areas

  • Neuroscience(all)
  • Biochemistry

Cite this

Early treatment with cyclosporin a ameliorates the reduction of muscarinic acetylcholine receptors in gerbil hippocampus after transient forebrain ischemia. / Kondo, Yoichi; Asanuma, Masato; Iwata, Emi; Kondo, Fumio; Miyazaki, Ikuko; Ogawa, Norio.

In: Neurochemical Research, Vol. 24, No. 1, 1999, p. 9-13.

Research output: Contribution to journalArticle

@article{7c29d75fa6a74a05bee8feab95ea30f7,
title = "Early treatment with cyclosporin a ameliorates the reduction of muscarinic acetylcholine receptors in gerbil hippocampus after transient forebrain ischemia",
abstract = "Recent evidence has suggested that cyclosporin A (CsA), an immunosuppressive agent, has neuroprotective properties. However, its mechanisms associated with this activity remain unclear. We have previously shown that post-ischemic administration of CsA daily for 14 days prevented the decrease of muscarinic acetylcholine receptor binding in the hippocampus in the gerbil model of 5-min transient forebrain ischemia. In the present study, CsA (5 mg/kg, subcutaneously) was administered to each animal just after, 2 and 6 h after ischemia so as not to exert its immunosuppressive effect. Initial CsA treatment significantly restored the declined muscarinic acetylcholine receptor binding of the hippocampus 14 days after ischemia similar to the previous report. However, CsA did not alter reactive changes of astrocytes and microgila in the CA1 area of the hippocampus, which had been suppressed by daily administration. These results indicate that CsA could positively modulate the hippocampal acetylcholine neurotransmission system broken down through the ischemia-induced pyramidal cell death and its action mechanism may have no relation to the immunosuppressive properties.",
keywords = "Acetylcholine receptor, Cyclosporin A, Gerbil, Hippocampus, Ischemia",
author = "Yoichi Kondo and Masato Asanuma and Emi Iwata and Fumio Kondo and Ikuko Miyazaki and Norio Ogawa",
year = "1999",
doi = "10.1023/A:1020915727119",
language = "English",
volume = "24",
pages = "9--13",
journal = "Neurochemical Research",
issn = "0364-3190",
publisher = "Springer New York",
number = "1",

}

TY - JOUR

T1 - Early treatment with cyclosporin a ameliorates the reduction of muscarinic acetylcholine receptors in gerbil hippocampus after transient forebrain ischemia

AU - Kondo, Yoichi

AU - Asanuma, Masato

AU - Iwata, Emi

AU - Kondo, Fumio

AU - Miyazaki, Ikuko

AU - Ogawa, Norio

PY - 1999

Y1 - 1999

N2 - Recent evidence has suggested that cyclosporin A (CsA), an immunosuppressive agent, has neuroprotective properties. However, its mechanisms associated with this activity remain unclear. We have previously shown that post-ischemic administration of CsA daily for 14 days prevented the decrease of muscarinic acetylcholine receptor binding in the hippocampus in the gerbil model of 5-min transient forebrain ischemia. In the present study, CsA (5 mg/kg, subcutaneously) was administered to each animal just after, 2 and 6 h after ischemia so as not to exert its immunosuppressive effect. Initial CsA treatment significantly restored the declined muscarinic acetylcholine receptor binding of the hippocampus 14 days after ischemia similar to the previous report. However, CsA did not alter reactive changes of astrocytes and microgila in the CA1 area of the hippocampus, which had been suppressed by daily administration. These results indicate that CsA could positively modulate the hippocampal acetylcholine neurotransmission system broken down through the ischemia-induced pyramidal cell death and its action mechanism may have no relation to the immunosuppressive properties.

AB - Recent evidence has suggested that cyclosporin A (CsA), an immunosuppressive agent, has neuroprotective properties. However, its mechanisms associated with this activity remain unclear. We have previously shown that post-ischemic administration of CsA daily for 14 days prevented the decrease of muscarinic acetylcholine receptor binding in the hippocampus in the gerbil model of 5-min transient forebrain ischemia. In the present study, CsA (5 mg/kg, subcutaneously) was administered to each animal just after, 2 and 6 h after ischemia so as not to exert its immunosuppressive effect. Initial CsA treatment significantly restored the declined muscarinic acetylcholine receptor binding of the hippocampus 14 days after ischemia similar to the previous report. However, CsA did not alter reactive changes of astrocytes and microgila in the CA1 area of the hippocampus, which had been suppressed by daily administration. These results indicate that CsA could positively modulate the hippocampal acetylcholine neurotransmission system broken down through the ischemia-induced pyramidal cell death and its action mechanism may have no relation to the immunosuppressive properties.

KW - Acetylcholine receptor

KW - Cyclosporin A

KW - Gerbil

KW - Hippocampus

KW - Ischemia

UR - http://www.scopus.com/inward/record.url?scp=0032938491&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032938491&partnerID=8YFLogxK

U2 - 10.1023/A:1020915727119

DO - 10.1023/A:1020915727119

M3 - Article

C2 - 9973231

AN - SCOPUS:0032938491

VL - 24

SP - 9

EP - 13

JO - Neurochemical Research

JF - Neurochemical Research

SN - 0364-3190

IS - 1

ER -